O
CVD

OrbiMed’s COVANCE INC. CVD Stock Holding History

OrbiMed’s Portfolio CVD Stock Details CVD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-63,000
Closed -$6.55M – 154
2014
Q1 		$6.55M Buy
63,000
+4,000
+7% +$396K 0.08% 110
2013
Q4 		$5.2M Buy
59,000
+11,000
+23% +$952K 0.08% 96
2013
Q3 		$4.15M Hold
48,000
– – 0.07% 106
2013
Q2 		$3.65M Buy
+48,000
New +$3.59M 0.08% 109

Other funds holding CVD

Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

OrbiMed's CVD Position: Q2 2014 in Review

OrbiMed sold out of COVANCE INC. (CVD) in Q2 2014, closing a stake of 63,000 shares — an estimated $6.55M sold.

OrbiMed first reported a position in CVD in Q2 2013 and held it in 4 quarters. The position peaked at $6.55M in Q1 2014. 291 funds tracked by Wall St. Rank hold CVD as of Q2 2014.

  • OrbiMed reported no remaining COVANCE INC. position as of Q2 2014 after selling out during the quarter.
  • OrbiMed sold 63,000 COVANCE INC. shares in Q2 2014, an estimated $6.55M.
  • OrbiMed first reported a position in COVANCE INC. in Q2 2013 and held it in 4 quarters.
  • OrbiMed's COVANCE INC. position peaked at $6.55M in Q1 2014.
  • 291 funds tracked by Wall St. Rank held COVANCE INC. as of Q2 2014.

Based on OrbiMed's 13F filing for Q2 2014, filed 14 Aug 2014.